Model N survey shows 35% of US adults delay or skip prescriptions amid price uncertainty
Bitget2026/09/23 14:06- Model N analysis found 35% of U.S. adults delayed, stretched, or skipped prescriptions due to unclear costs.
- Survey showed 46% do not consistently know prescription prices before reaching the pharmacy; 58% took cost-containment actions due to uncertainty.
- Expected costs influenced treatment decisions for 46%, raising risk of non-initiation, substitution, or dose rationing that can pressure branded-drug demand.
- Price shopping increased: 72% checked prices using at least one method; 40% more likely to check than a year ago.
- Stakeholder opacity persists: 76% had never heard of PBMs or did not know their role, complicating formulary-driven access strategies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
